Deletion Mutants, Archived Transposon Library, and Tagged Protein Constructs of the Model Sulfate-Reducing Bacterium Desulfovibrio vulgaris Hildenborough

The dissimilatory sulfate-reducing deltaproteobacterium Desulfovibrio vulgaris Hildenborough (ATCC 29579) was chosen by the research collaboration ENIGMA to explore tools and protocols for bringing this anaerobe to model status. Here, we describe a collection of genetic constructs generated by ENIGMA that are available to the research community.

T he study of sulfate-reducing microorganisms (SRMs) is necessitated by the multitude of impacts caused by their metabolism on Earth's sulfur, oxygen, and carbon cycles (1,2), their corrosion of concrete and ferrous metal structures (3,4), and their involvement in human health (5). Recently, possible SRM contributions to biohydrogen and hydrocarbons for biofuel, polyhydroxyalkanoates to replace plastics, bioremediation of toxic metals, and bioactive metal sulfides for cancer treatment have been revealed (2). With 28 mM sulfate in the oceans, SRMs have a competitive advantage for biomass turnover there. Estimates of SRM degradation of about 50% of the organic matter reaching the marine sediment (1, 6) would make them among the more abundant organisms on Earth.
Because of the environmental importance of these microbes, the first sulfate-reducing bacterium with a sequenced genome, Desulfovibrio vulgaris Hildenborough (7), was chosen to be brought to model status for use in generating a transposon (Tn) library and for constructing strains that produce affinity-tagged proteins (Table 1). In the Dryad digital repository, we provide a list of the Hildenborough constructs and a ReadMe file that describes their construction (9). Below, references are included where construction details can be found.
Marker exchange mutation, replacing a nucleotide sequence with a selectable marker flanked by homologous chromosomal regions, has been the cornerstone of genetic constructions (10,11). To generate in-frame deletions without a residual selectable marker, a parental strain, JW710, was created that is resistant to inhibition by 5fluorouracil through deletion of the uracil phosphoribosyltransferase (upp) gene (12). The return of the upp gene restores sensitivity, providing a counterselectable gene. JW710 also allows site-directed mutations (13) and multiple deletions to be created without an accumulation of selectable markers (12,14). The plasmids, pSC27 (15), pMO719 (16), pMO9075 (11), and pMO746 (17), with features used in various strain constructions, are available from https://www.addgene.org/Judy_Wall/.
Transposon mutants were generated by conjugation of a nonreplicating plasmid encoding a mini-Tn5 (18) conferring kanamycin (and Geneticin) resistance and modified with barcoding oligonucleotide sequences (19,20). Kanamycin-resistant transconjugants were recovered from transposition events and subjected to sequencing to locate the insertion site of the transposed DNA. Over 10,000 transconjugants were isolated and archived individually. Pools of these transposon mutants marked with TagModules were made to assay gene fitness in parallel (19), but their use revealed that unidentified members had an aerobic contaminant(s). Confirmation of the axenic status and the genome location of the transposon should be performed prior to use of these mutants. Randomly barcoded TnSeq approaches (21) have since been used to make pooled transposon libraries successfully in Hildenborough. These pooled bar-coded transposon mutants are also available upon request (22; V. Trotter, personal communication, 27 August 2020).
Affinity-tagged gene constructs were made for affinity purification to identify protein-protein interactions (23,24). Sequential tags were Strep-tag (25) and FLAG (26), separated by the tobacco etch virus (TEV) protease site (27), referred to as STF or STF with 6Â His for C-terminal tagging. Single-tagged constructs with SNAP allowed in vivo covalent tagging with a fluorescent dye (28).
Data availability. The genetic constructs described herein are available, within reason, from Valentine V. Trotter (vvtrotter@lbl.gov) and Adam M. Deutschbauer (amdeutschbauer@lbl.gov). The constructs can be found listed at the Dryad digital repository (https://doi.org/10.5061/dryad.h70rxwdh9). These strains were generated, wholly or in part, in the laboratory of Judy D. Wall, and the list was deposited in 2021. A ZIP file was deposited at Dryad containing a ReadMe document, a composite Excel file, an Excel file necessary for TagModule/barcode identification of transposon mutants and of complementary barcoded gene deletions, and a text file listing of TagModules. On sheet 1 in the composite Excel file is a search engine that will identify all constructs available for any gene locus provided as a DVU number. We thank all members of the ENIGMA Scientific Focus Program for stimulating discussion and sharing data, with special gratitude to Paul Adams, the SFA laboratory research manager, and Astrid Terry, the project manager. In addition, we thank the Biochemistry Division of the College of Agriculture, Food, and Natural Resources of the University of Missouri-Columbia. J.D.W. designed and supervised the marker replacement and markerless deletions, interpreted the data, and wrote the repository manuscript. G.M.Z. made and archived the Tn mutant library, made boutique mutations, and prepared the Excel files for the repository. T.R.J. made affinity-tagged constructs and bar-coded deletion (BCD) strains with plasmids from LBNL collaborators. J.V.K. helped develop and shared the procedures for the Tn library construction and archiving. J.R. sequenced the Hildenborough transposon mutants and generated the plasmids to make the BCD strains. S.R.C. oversaw highthroughput construction of engineered plasmids for affinity-tagged strains, in addition to drafting supporting manuscripts. V.V.T. generated pooled, barcoded Tn mutants of Hildenborough and is the curator of the genetic construct collection from the Wall Lab. M.S. interpreted the protein complex data from affinity-tagged strains of Hildenborough. K.B.D.L. developed methods and created site-directed mutations. K.L.K. developed genetic methods, made deletion strains, and interpreted results. K.S.B. created the parental strain for markerless deletions. G.B. designed, performed, and interpreted experiments with affinity-tagged strains and guided the generation of pooled transposon mutants of Hildenborough. A.P.A. visualized the SFA, provided supervision, and directed the research effort toward productive goals. A.M.D. coordinated high-throughput plasmid creation for Tn and BCD mutants and will host the collection of genetic constructs. All authors read and edited the manuscript and data set repository and approved the publication.